You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Technology Assisted Treatment for Trichotillomania
SBC: HABITAWARE, INC. Topic: 102Abstract Significance: Trichotillomania (TTM), characterized by repeated pulling of one’s hair to the point of hair loss or thinning, produces impairment in physical, social, psychological and occupational functioning. While evidenced-based treatments (EBTs, i.e. self-monitoring, stimulus control, and Habit Reversal Training (HRT)) do exist, access is limited due to lack of trained treatment pro ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Broadly Accessible Technologies for Single-cell Joint Analysis of Transcriptome and Epigenome
SBC: EPIGENOME TECHNOLOGIES, INC Topic: 101AbstractHistone modifications carry rich information of cellular memory and gene regulatory mechanisms. Single cell analysis of histone modification in conjunction with transcriptome could recover this critical layer of cell identity and help to dissect the cellular and molecular composition of complex tissues such as the brain. We recently developed an ultra-high throughput single cell multi-omic ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Improving Patient Care Through Objective Monitoring of At-Home Repetitive Ritual Behaviors in Obsessive-Compulsive Disorder
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: 104Project Summary Obsessive-compulsive disorder (OCD) is characterized by intrusive, distressing thoughts (obsessions) in response to which an individual feels compelled to perform a repetitive behavior (compulsions), which are performed in order to reduce the acute distress experienced by the patient but which perpetuate OCD symptoms. Effective treatment requires accurate reporting of compulsive be ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
MentorHub: A Supportive Accountability Tool for MHapps
SBC: ACADEMIC WEB PAGES, INC Topic: 104Project Summary/Abstract (30 lines) In the United States, 15 million children and adolescents need psychological services; yet only one-third receive psychological services of any kind. Even fewer receive care that is consistent with evidence-based guidelines for best practices. This gap has widened dramatically with the negative effects of the COVID-19 pandemic on the mental health of children, c ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Microscope system for large scale optical imaging of neuronal activity using kilohertz frame rates
SBC: MICROBRIGHTFIELD, LLC Topic: 105Abstract This project aims to develop the 2P-ActivityScope™, a revolutionary new microscope based on a technological breakthrough called second-generation Scanned Line Angular Projection (SLAP2) two photon laser scanning microscopy that was recently developed by Dr. Kaspar Podgorski (Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA). The game-changing innovation in the 2P-Ac ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Commercialization readiness of visual biofeedback to reduce head motion during MRI scans
SBC: TURING MEDICAL TECHNOLOGIES INC Topic: NIMHProject Abstract/SummaryThe goal of this CRP application is to successfully commercialize a brain MRI technology that feeds back head motion measurements derived from our Framewise Integrated Real-Time MRI Monitoring (FIRMM) software to MRI scan participants in order to reduce head motion via behavioral training. Because MRI scanning produces high-resolution images and does not expose patients to ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Automated microfluidic hyperpolarization reactor for neurometabolic imaging
SBC: VIZMA LIFE SCIENCES INC Topic: 101Abstract Brain function is regulated by molecular signaling and metabolism, however, our ability to track neurometabolic transformations deep in the brain is very underdeveloped compared to the central role of neurometabolism in neurodegenerative disease or brain function in general. In this Phase I SBIR, it is our goal to establish and refine emergent hyperpolarization technology as an inexpensiv ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Novel platform for optimizing AAV transgene expression to improve efficacy of ocular gene therapies
SBC: Epigenos Bioscience, Inc. Topic: 100Abstract Gene therapy applications based on adeno-associated virus (AAV) have demonstrated promise in clinical applications for the treatment of diverse genetic diseases highlighted by the recent FDA approval of AAV vector formulations as new drugs for ocular and neurological diseases. In these instances, along with all applications of clinical AAV gene therapy to date, constitutive transcription ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Cell permeant peptidomimetics to prevent delayed vasospasm and neurological deficits after subarachnoid hemorrhage
SBC: VasaMetrix Topic: 107PROJECT SUMMARYSubarachnoid hemorrhage (SAH) due to rupture of an intracranial aneurysm leads to delayed vasospasm resulting in neuroischemia (stroke). The overall morbidity (profound neurologic deficit in 10-20% of survivors) and mortality (50%) are high, and the disease affects a relatively young adult population. Therapeutic options to prevent delayed vasospasm and neuroischemia after SAH are c ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells
SBC: AFFIRMED PHARMA, LLC Topic: NEICancer patients benefit from radiation therapy but can incur side effects to normal tissues including the ocular lens, leading to cataracts. Although not directly life threatening, cataract disease has major medical, economic, and social impacts on individuals, families, and society as a whole. Radiation-induced lens opacification is a complex event and has been attributed to DNA double strand bre ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health